Adenosine receptor agonist |
∼20 |
Rat |
Preston et al. (2000) |
CGRP |
∼60* |
Rat |
Watts and Cohen (1991) |
|
∼45 |
Rat |
Ventura et al. (2000b) |
α-adrenoceptor antagonist |
∼65 |
Mouse |
Gray and Ventura (2005) |
|
∼50 |
Mouse |
White et al. (2010) |
|
∼40 |
Rat |
Najbar-Kaszkiel et al. (1997) |
|
∼45 |
Rat |
Ventura et al. (2003) |
|
∼50 |
Guinea-pig |
Buljubasich and Ventura (2004) |
|
∼40 |
Guinea-pig |
Najbar-Kaszkiel et al. (1997) |
|
∼50 |
Rabbit |
Najbar-Kaszkiel et al. (1997) |
|
∼90 |
Pig |
Najbar-Kaszkiel et al. (1997) |
β-adrenoceptor agonist |
∼60 |
Rat |
Kalodimos and Ventura (2001) |
|
∼60* |
Guinea-pig |
Haynes and Hill (1997) |
PGE2
|
∼65 |
Rat |
Tokanovic et al. (2007) |
|
∼65 |
Rat |
Tokanovic et al. (2010) |
Nitric oxide donors |
100* |
Rat |
Najbar-Kaszkiel et al. (1997) |
|
∼70* |
Guinea-pig |
Najbar-Kaszkiel et al. (1997) |
|
∼75* |
Rabbit |
Najbar-Kaszkiel et al. (1997) |
|
∼70* |
Pig |
Najbar-Kaszkiel et al. (1997) |
|
∼45* |
Human |
Hedlund et al. (1997) |
CB-cannabinoid receptor agonist |
∼75 |
Rat |
Tokanovic et al. (2007) |
|
<73* |
Human |
Gratzke et al. (2010) |
P2X-purinoceptor blocker |
100 |
Mouse |
Gray and Ventura (2005) |
|
100 |
Mouse |
White et al. (2010) |
|
∼70 |
Rat |
Ventura et al. (2003) |
|
∼70 |
Guinea-pig |
Buljubasich and Ventura (2004) |
Muscarinic receptor antagonist |
∼80 |
Mouse |
Gray and Ventura (2005) |
|
∼75 |
Mouse |
White et al. (2010) |
|
100 |
Rat |
Najbar-Kaszkiel et al. (1997) |
|
∼85 |
Guinea-pig |
Najbar-Kaszkiel et al. (1997) |
|
∼80 |
Rabbit |
Najbar-Kaszkiel et al. (1997) |
|
100 |
Pig |
Najbar-Kaszkiel et al. (1997) |
ET-endothelin receptor antagonist |
100 |
Rat |
Salamoussa et al. (2000) |
|
100 |
Guinea-pig |
Lau et al. (1999) |
Histamine receptor antagonist |
100 |
Guinea-pig |
Kerr (2006) |
NK-tachykinin receptor antagonist |
100 |
Guinea-pig |
Buljubasich et al. (1999) |